Susquehanna International Group, LLP I Teos Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$10.33 - $18.09 $14.4 Million - $25.2 Million	1,395,000 New	1,395,000 $20.7 Million
Q4 2023 Feb 14, 2024	BUY	$8.57 - $11.06 $4.31 Million - $5.57 Million	503,500 Added 267.39%	691,800 $7.58 Million
Q3 2023 Nov 14, 2023	BUY	$10.95 - $14.6 $1.48 Million - $1.98 Million	135,600 Added 257.31%	188,300 $2.06 Million
Q2 2023 Aug 11, 2023	BUY	$12.93 - $18.05 $310,320 - $433,200	24,000 Added 83.62%	52,700 $697,000
Q1 2023 May 16, 2023	BUY	$13.02 - $22.62 $373,674 - $649,194	28,700 New	28,700 $390,000

149

36.3M

653K

1.48M

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $356M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.